Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 28Lymphoma, Mantle-Cell 14Lymphoma, Non-Hodgkin 8Lymphoma, Large B-Cell, Diffuse 5Lymphoma 5Leukemia, B-Cell 4Multiple Myeloma 3Lymphoma, B-Cell 3Waldenstrom Macroglobulinemia 2Recurrence 2Pancreatic Neoplasms 2Lymphoma, Follicular 2Lymphatic Diseases 2Leukemia, Prolymphocytic 2Leukemia 2Squamous Cell Carcinoma of Head and Neck 1Part1: Advanced B-cell Malignancies 1Ovarian Neoplasms 1Neoplasms 1Lymphoproliferative Disorders 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Hairy Cell 1Immunoproliferative Disorders 1Immune System Diseases 1Hodgkin Disease 1Hematologic Neoplasms 1Hematologic Diseases 1Heart Failure 1Glioblastoma 1DLBCL 1

Interventions

Rituximab 8dacetuzumab 5blinatumomab 5ibrutinib 3Cyclophosphamide 3tetulomab tetraxetan lu-177 2ponatinib 2cobomarsen 2acalabrutinib 2Vincristine 2Prednisone 2Lutetium 2Ifosfamide 2Everolimus 2Etoposide 2Doxorubicin 2Carboplatin 2venetoclax 1sepantronium 1pomalidomide 1obinutuzumab 1fludarabine 1ficlatuzumab 1enzalutamide 1durvalumab 1denileukin diftitox 1cirmtuzumab 1amonafide 1Vorinostat 1Tinzaparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Lymphatic Diseases × acalabrutinib × Clear all
NCT06651970 2026-05-18

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

AstraZeneca

Phase 4 Recruiting
60 enrolled
LymphoidOther hematologic neoplasm

Heart Failure, Lymphatic Diseases, Leukemia, B-Cell

NCT04529772 2026-03-31

ESCALADE

Acerta Pharma BV

Phase 3 Active not recruiting
611 enrolled
Lymphoid

Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡